Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 EntreMed To Open China Office, Ends SVT Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

EntreMed To Open China Office, Ends SVT Alliance

SVT will not retain any rights to ENMD-2076

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

EntreMed, Inc. plans to establish an office in China to facilitate its drug development and clinical trials in the region. Additionally, EntreMed and Selected Value Therapeutics, LLC (SVT) have terminated their agreement regarding SVT’s right to enter into a license agreement to develop and commercialize the company’s lead compound, ENMD-2076, in China and certain of its territories. SVT agreed to terminate the agreement in order to allow the company greater flexibility to execute its global drug development strategy.
 
Dr. Wei-Wu He, EntreMed’s executive chairman of the board, said, “Our recent strategic financing, led by IDG-Accel, provided an opportunity for the company to assess its clinical strategy and new resources to accelerate the development of targeted drug candidates, such as ENMD-2076, by using a global approach to conducting high quality clinical trials, with an emphasis in China and the U.S. Establishing an operation in China will facilitate building deeper relationships with local medical institutions, regulatory agencies and broader sources of capital. We will also continue to be opportunistic about the timing and terms of financing opportunities in both the U.S. and China. We believe this global approach will be a key driver to build value for our shareholders.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics